News | November 08, 2021
Divis Labs PAT at Rs 606.46 cr. in Q2FY22
Divi's Laboratories Limited has reported consolidated financial results for the period ended September 30, 2021.
Divi's Laboratories Limited has reported consolidated financial results for the period ended September 30, 2021.
Applications remain under review by others including U.S. Food and Drug Administration and the European Medicines Agency
Expertise in exosomes isolation and characterization will drive innovation in this field
The Board of Directors of Caplin Point Laboratories at its meeting have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021
The Thermo Scientific Orbitrap Exploris MX enables customer success by combining high-quality data with operational simplicity
Dr Lal PathLabs revenue contribution from west India to go up from 10% to 24% post-acquisition basis FY21
Pluss Advanced Technologies (PLUSS), has led the growth of energy storage materials across applications. Their proprietary Phase Change Material has gained wide acceptance in the pharmaceutical, logistics and food industries. The varied demands of the industry during Covid-19 has brought its technology into focus. Samit Jain, MD, PLUSS in conversation with Thomas C Thottathil discusses trends and outlines his plans for the business
The new products include the COAG Line automated, semi-automated and POC systems manufactured by Diagon Hungary
The Amplitude Solution gives laboratories the ability to scale Covid-19 PCR testing and process up to 8,000 samples a day
It is the first presbyopia-correcting lens implant for cataract surgery
Subscribe To Our Newsletter & Stay Updated
